The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer

Jiyeon Kim, Hyun Min Lee, Feng Cai, Bookyung Ko, Chendong Yang, Elizabeth L. Lieu, Nefertiti Muhammad, Shawn Rhyne, Kailong Li, Mohamed Haloul, Wen Gu, Brandon Faubert, Akash Kaushik, Ling Cai, Sahba Kasiri, Ummay Marriam, Kien Nham, Luc Girard, Hui Wang, Xiankai Sun, James Kim, John D. Minna, Keziban Ünsal-Kaçmaz, Ralph J. DeBerardinis, Keziban Ünsal-Kaçmaz, Ralph J. DeBerardinis